Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555

Report Image
In Vitro Fertilization Market in Asia Pacific - Country Analysis by End Users (Clinics, Hospitals, Surgical Centers, Clinical Research Institutes, Banks) Number of Cycles, Revenue, Market Share, Growth, Trends, and Forecast Through 2020
Published: March-2014    |    Formats: PDF & Excel   |   Author(s):Debbie Shields   |   Code: ME 14186
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology
  • Analyst's
    Review

Pages
105

The advancement of IVF market in Asia Pacific is characterized by major factors such as the rising standards of living and growing number of couples delaying parenthood due to professional and financial commitments. The Asia Pacific IVF market, valued at $1.3 billion in 2012, is estimated to reach $4.2 billion by 2020. As the chances of conceiving lowers with age, delayed pregnancy in women is one of the major driving factors of the IVF market. The success rate of getting pregnant with IVF technique is higher within the age group of 35-39. Other driving factors of the IVF market are rise in infertility rates due to rise in stress levels, change in life style and fertility related diseases.

Asia, in particular is facing the challenge of aging population and lower work force replacement. These trends would impact the socio-economic development and progress. Many countries in Asia Pacific region such as Japan, North and South Korea, China, Vietnam, Singapore and Thailand have fertility rates that are way below the replacement fertility levels. According to the East West center study, countries such as Japan, South Korea, Singapore, Taiwan, etc., Asia’s prosperous economies have the lowest birth rate worldwide.

Taiwan has the lowest birth per women which is 0.91 (2010) when compared with South Korea (1.15), Japan (1.39) and Singapore (1.16). This trend is due to couples postponing parenthood, couples preferring few children or rather no children at all.

Countries in Asia Pacific with such lower levels of fertility have initiated innovative assistance programs to promote parenthood and provide subsidies on fertility treatments such as IVF. In addition, lower treatment cost as compared to western countries has also proved to be positive for the artificial reproductive treatment (ART) industry in the region. With the advancing technologies, the success ratio of ART, especially IVF, has also grown in the region. Together, these factors have not only provided the region with an opportunity to improve on its birth rates, but also have added to the growth of the medical tourism industry in the region. Due to the rising trend in Medical tourism, many countries such as Malaysia, Thailand, Singapore, and India are gaining popularity.

In Vitro Fertilization Market in Asia Pacific-Another investing platform

KEY BENEFITS

  • In-depth analysis of the IVF market in 12 major country market with a cross sectional analysis of  end users segments
  • Quantitative analysis of the current market and estimations through 2013-2020
  • Assessment and ranking of the factors affecting the global market and impact analysis of the same
  • Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region

COVERAGE

For the purpose of better understanding of the market, the report has covered 12 country markets and has presented a cross sectional analysis of each country market for end user segments. Both revenue and number of IVF cycles performed at various end use segments is calculated based on various indicators, authentic secondary sources, government publications and primary research with leading IVF providers in each of the country. The qualitative analysis is carried out for each country market for major trends and market dynamics. The major countries covered in this study include:

  • India
  • China
  • Japan
  • Vietnam
  • Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Singapore

Each of these country markets has been analyzed for following end user segments:

  • Hospitals
  • Clinics
  • Surgical Centers
  • Research institutes
  • Banks

Apart from that, profiles of major market player in each of the country have also been provided for better understanding of market strategy and competitive scenario.


Tables
69

  

1. REPORT OUTLINE

1.1. Report Description
1.2. Key Benefits
1.3. Coverage
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Models

2. EXECUTIVE SUMMARY………………………………….CHAPTER PRICE: $299

3. ASIA PACIFIC IN VITRO FERTILIZATION (IVF) MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $1,499

 3.1. Overview
 3.2. IVF Pricing Trends by Country
 3.3. IVF Cycles by Country
 3.4. Drivers
 3.5. Restraints
 3.6. Opportunities

 3.7. Market by End User

3.7.1. Fertility clinics
3.7.2. Hospitals
3.7.3. Surgical centers
3.7.4. Banks
3.7.5. Clinical research institutes

3.8. Profiles of Major Players

3.8.1. Thermo Fisher Scientific Inc.

3.8.1.1. Company overview
3.8.1.2. Company snapshot
3.8.1.3. Financial overview
3.8.1.4. Market share
3.8.1.5. Strategic moves and developments

3.8.2. EMD Serono, Inc.

3.8.2.1. Company overview
3.8.2.2. Company snapshot
3.8.2.3. Financial overview
3.8.2.4. Market share
3.8.2.5. Strategic moves and developments

3.8.3. Sun Pharmaceutical

3.8.3.1. Company overview
3.8.3.2. Company snapshot
3.8.3.3. Financial overview
3.8.3.4. Market share
3.8.3.5. Strategic moves and developments

3.8.4. Cadila Healthcare Ltd.

3.8.4.1. Company overview
3.8.4.2. Company snapshot
3.8.4.3. Financial overview
3.8.4.4. Market share
3.8.4.5. Strategic moves and developments

3.8.5. LG Life Sciences.

 3.8.5.1. Company overview
3.8.5.2. Company snapshot
3.8.5.3. Financial overview
3.8.5.4. Market share
3.8.5.5. Strategic moves and developments

4. CHINA IVF MARKET (REVENUE AND NUMBER OF CYCLES)………………………………….CHAPTER PRICE: $799

4.1. Number of Cycles by Hospitals/Clinics

4.2. Market by End User

4.2.1. Fertility clinics
4.2.2. Hospitals
4.2.3. Surgical centers
4.2.4. Banks
4.2.5. Clinical research institutes

4.3. Drivers
4.4. Restraints
4.5. Regulatory issues, legislations and authorities
4.6. Insurance reimbursement scenario
4.7. Profiles of Major Players (Reproductive & and genetic Hospital Citic-Xiangya, Shenyang Hospital, China, IVF Center China, Shandong Provincial Hospital, China, Centre for Reproductive Medicine China)

4.7.1. Company overview
4.7.2. Company snapshot
4.7.3. Financial overview
4.7.4. Market share
4.7.5. Strategic moves and developments

5. JAPAN IVF MARKET (REVENUE AND NUMBER OF CYCLES)………………………………….CHAPTER PRICE: $699

5.1. Number of Cycles by Hospitals/Clinics
5.2. Market by End User

5.2.1. Fertility clinics
5.2.2. Hospitals
5.2.3. Surgical centers
5.2.4. Banks
5.2.5. Clinical research institutes

5.3. Drivers
5.4. Restraints
5.5. Regulatory issues, legislations and authorities
5.6. Insurance reimbursement scenario
5.7. Profiles of Major Players (Hiroshima Hart Clinic, IVF Japan, The Advanced Reproductive Technological Institute (ARMT), Yoshida Ladies Clinic Reproductive ART Center, Iwaki-Women's Clinic)

5.7.1. Company overview
5.7.2. Company snapshot
5.7.3. Financial overview
5.7.4. Market share
5.7.5. Strategic moves and developments

6. KOREA IVF MARKET (REVENUE AND NUMBER OF CYCLES)………………………………….CHAPTER PRICE: $799

6.1. Number of Cycles by Hospitals/Clinics
6.2. Market by End User

6.2.1. Fertility clinics
6.2.2. Hospitals
6.2.3. Surgical centers
6.2.4. Banks
6.2.5. Clinical research institutes

6.3. Regulatory issues, legislations and authorities
6.4. Insurance reimbursement scenario
6.5. Profiles of Major Players (Maria Fertility Hospital, Cha General Hospital, Seoul National University Hospital IVF Center, Dongtan Cheil Women's Clinic Ajou University)

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Financial overview
6.5.4. Market share
6.5.5. Strategic moves and developments

7. INDIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)………………………………….CHAPTER PRICE: $799

7.1. Number of Cycles by Hospitals/Clinics
7.2. Market by End User

7.2.1. Fertility clinics
7.2.2. Hospitals
7.2.3. Surgical centers
7.2.4. Banks
7.2.5. Clinical research institutes

7.3. Regulatory issues, legislations and authorities
7.4. Insurance reimbursement scenario
7.5. Profiles of Major Players (Bourn Hall Clinic, Southend Fertility and IVF Centre, Morpheus IVF Fertility Center, Bloom Fertility Center, Manipal Ankur, Cloudnine Fertility, Nova IVI Fertility)

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Financial overview
7.5.4. Market share
7.5.5. Strategic moves and developments

8. AUSTRALIA IVF MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $699

8.1. Number of Cycles by Hospitals/Clinics
8.2. Market by End User

8.2.1. Fertility clinics
8.2.2. Hospitals
8.2.3. Surgical centers
8.2.4. Banks
8.2.5. Clinical research institutes

8.3. Regulatory issues, legislations and authorities
8.4. Insurance reimbursement scenario
8.5. Profiles of Major Players (Virtus Health, Monash IVF, Genea Limited, City Fertility, Flindersfertility)

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Financial overview
8.5.4. Market share
8.5.5. Strategic moves and developments

9. NEW ZEALAND IVF MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $699

9.1. Number of Cycles by Hospitals/Clinics
9.2. Market by End User

9.2.1. Fertility clinics
9.2.2. Hospitals
9.2.3. Surgical centers
9.2.4. Banks
9.2.5. Clinical research institutes

9.3. Regulatory issues, legislations and authorities
9.4. Insurance reimbursement scenario
9.5. Profiles of Major Players (Fertility Associates New Zealand, Fertility Plus, Repromed)

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Financial overview
9.5.4. Market share
9.5.5. Strategic moves and developments

10. SOUTH-EAST ASIA IVF MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $3,999

10.1. Number of Cycles by Hospitals/Clinics
10.2. Market by End User

10.2.1. Fertility clinics
10.2.2. Hospitals
10.2.3. Surgical centers
10.2.4. Banks
10.2.5. Clinical research institutes

10.3. Regulatory issues, legislations and authorities
10.4. Insurance reimbursement scenario

 10.5. SINGAPORE IVF MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $799

10.5.1. Number of Cycles by Hospitals/Clinics
10.5.2. Market by End User

10.5.2.1. Fertility clinics
10.5.2.2. Hospitals
10.5.2.3. Surgical centers
10.5.2.4. Banks
 10.5.2.5. Clinical research institutes

10.5.3. Regulatory issues, legislations and authorities
10.5.4. Insurance reimbursement scenario
10.5.5. Profiles of Major Players (NUH IVF Centre, Thomson Fertility Centre, Mount Elizabeth Fertility Center, Parkview Fertility Centre, Raffles Fertility Centre)

10.5.5.1. Company overview
10.5.5.2. Company snapshot
10.5.5.3. Financial overview
10.5.5.4. Market share
10.5.5.5. Strategic moves and developments

 10.6. MALAYSIA IVF MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $799

10.6.1. Number of Cycles by Hospitals/Clinics
10.6.2. Market by End User

10.6.2.1. Fertility clinics
10.6.2.2. Hospitals
10.6.2.3. Surgical centers
10.6.2.4. Banks
10.6.2.5. Clinical research institutes

10.6.3. Regulatory issues, legislations and authorities
10.6.4. Insurance reimbursement scenario
10.6.5. Profiles of Major Players (Subang Fertility Center Subang Jaya Hospital, TMC Fertility Center formerly known as Damansara Fertility center, Fertility Centre Scaudinavia, Concept Fertility Center (Malaysia), Medically Assisted Conception Centre)

10.6.5.1. Company overview
10.6.5.2. Company snapshot
10.6.5.3. Financial overview
10.6.5.4. Market share
10.6.5.5. Strategic moves and developments

 10.7. INDONESIA IVF MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $799

10.7.1. Number of Cycles by Hospitals/Clinics
10.7.2. Market by End User

10.7.2.1. Fertility clinics
10.7.2.2. Hospitals
10.7.2.3. Surgical centers
10.7.2.4. Banks
10.7.2.5. Clinical research institutes

10.7.3. Regulatory issues, legislations and authorities
10.7.4. Insurance reimbursement scenario
10.7.5. Profiles of Major Players (Anugerah Fertility Center, Morula IVF, Fertility Centre, Siloam Hospitals Surabana, Aster Fertility Clinic, Yasmin IVF)

10.7.5.1. Company overview
10.7.5.2. Company snapshot
10.7.5.3. Financial overview
10.7.5.4. Market share
10.7.5.5. Strategic moves and developments

 10.8. PHILIPPINES IVF MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $799

10.8.1. Number of Cycles by Hospitals/Clinics
10.8.2. Market by End User

10.8.2.1. Fertility clinics
10.8.2.2. Hospitals
10.8.2.3. Surgical centers
10.8.2.4. Banks
10.8.2.5. Clinical research institutes

10.8.3. Regulatory issues, legislations and authorities
10.8.4. Insurance reimbursement scenario
10.8.5. Profiles of Major Players (Center for Reproductive Medicine, Victory Art Lab, CRM-MIA-Philippines)

10.8.5.1. Company overview
10.8.5.2. Company snapshot
10.8.5.3. Financial overview
10.8.5.4. Market share
10.8.5.5. Strategic moves and developments

 10.9. THAILAND IVF MARKET (REVENUE AND NUMBER OF CYCLES) ………………………………….CHAPTER PRICE: $799

10.9.1. Number of Cycles by Hospitals/Clinics
10.9.2. Market by End User

10.9.2.1. Fertility clinics
10.9.2.2. Hospitals
10.9.2.3. Surgical centers
10.9.2.4. Banks
10.9.2.5. Clinical research institutes

10.9.3. Regulatory issues, legislations and authorities
10.9.4. Insurance reimbursement scenario
10.9.5. Profiles of Major Players (Bangkok Fertility Center, Jetanin Institute for Assisted Reproduction, Perfect Woman Institute Piyavate Hospital, Ramathibodi Hosp, Mahidol University, Bangkok Thailand, Siriraj Hospital)

10.9.5.1. Company overview
10.9.5.2. Company snapshot
10.9.5.3. Financial overview
10.9.5.4. Market share
10.9.5.5. Strategic moves and developments

 10.10. VIETNAM IVF MARKET (REVENUE AND NUMBER OF CYCLES)………………………………….CHAPTER PRICE: $799

10.10.1. Number of Cycles by Hospitals/Clinics
10.10.2. Market by End User

10.10.2.1. Fertility clinics
10.10.2.2. Hospitals
10.10.2.3. Surgical centers
10.10.2.4. Banks
10.10.2.5. Clinical research institutes

10.10.3. Regulatory issues, legislations and authorities
10.10.4. Insurance reimbursement scenario
10.10.5. Profiles of Major Players (IVF Center of National Hospital of GB. Gyn, IVF Lab Tu Du Hospital Vietnam, IVF Van Hanh, IVFAS, Tu Du - Ho Chi Minh City Vietnam)

10.10.5.1. Company overview
10.10.5.2. Company snapshot
10.10.5.3. Financial overview
10.10.5.4. Market share
10.10.5.5. Strategic moves and developments

 

LIST OF TABLES
TABLE 1    ASIA PACIFIC IVF CYCLES BY COUNTRY, 2012 – 2020 (THOUSAND)
TABLE 2    ASIA PACIFIC IVF REVENUE BY COUNTRY, 2012 – 2020 ($MILLION)
TABLE 3    ASIA PACIFIC IVF CYCLES BY END USER, 2012 – 2020 (THOUSAND)
TABLE 4    ASIA PACIFIC IVF REVENUE BY END USER, 2012 – 2020 ($MILLION)
TABLE 5    THERMO FISHER SCIENTIFIC INC  BUSINESS OVERVIEW
TABLE 6    COMPANY SNAPSHOT
TABLE 7    EMD SERONO INC BUSINESS OVERVIEW
TABLE 8    COMPANY SNAPSHOT
TABLE 9    SUN PHARMACEUTICAL BUSINESS OVERVIEW
TABLE 10  COMPANY SNAPSHOT
TABLE 11  CADILA HEALTH CARE BUSINESS OVERVIEW
TABLE 12  COMPANY SNAPSHOT
TABLE 13  LG LIFE SCIENCE  BUSINESS OVERVIEW
TABLE 14  COMPANY SNAPSHOT
TABLE 15  CHINA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 16  CHINA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 17  COOK MEDICAL INC BUSINESS OVERVIEW
TABLE 18  COMPANY SNAPSHOT
TABLE 19  VETROLIFE AB INC BUSINESS OVERVIEW
TABLE 20  COMPANY SNAPSHOT
TABLE 21  INDIA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 22  INDIA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 23  SUN PHARMACEUTICAL BUSINESS OVERVIEW
TABLE 24  COMPANY SNAPSHOT
TABLE 25  TRIVECTOR ORIGIO SCIENTIFIC  BUSINESS OVERVIEW
TABLE 26  COMPANY SNAPSHOT
TABLE 27  LAB IVF ASIA BUSINESS OVERVIEW
TABLE 28  COMPANY SNAPSHOT
TABLE 29  LG LIFE SCIENCE  BUSINESS OVERVIEW
TABLE 30  COMPANY SNAPSHOT
TABLE 31  CADILA HEALTH CARE  BUSINESS OVERVIEW
TABLE 32  COMPANY SNAPSHOT
TABLE 33  KOREA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 34  KOREA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 35  NEW ZEALAND IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 36  NEW ZEALAND IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 37  AUSTRALIA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 38  AUSTRALIA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 39  GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
TABLE 40  COMPANY SNAPSHOT
TABLE 41  THERMO FISHER SCIENTIFIC INC  BUSINESS OVERVIEW
TABLE 42  COMPANY SNAPSHOT
TABLE 43  JAPAN IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 44  JAPAN IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 45  EMD SERONO INC BUSINESS OVERVIEW
TABLE 46  COMPANY SNAPSHOT
TABLE 47  BIRTH RATE OF SOUTH-EAST ASIA PER THOUSAND, 2012
TABLE 48  SOUTH-EAST ASIA IVF REVENUE BY END USERS, 2012 – 2013 ($MILLION)
TABLE 49  SOUTH-EAST ASIA IVF REVENUE BY COUNTRY, 2012 – 2013 ($MILLION)
TABLE 50  SOUTH-EAST ASIA IVF CYCLES BY COUNTRY, 2012 – 2013 (THOUSAND)
TABLE 51  SOUTH-EAST ASIA IVF CYCLES BY END USER, 2012 – 2013 (THOUSAND)
TABLE 52  SINGAPORE IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 53  SINGAPORE IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 54  PACIFIC HEALTHCARE  BUSINESS OVERVIEW
TABLE 55  COMPANY SNAPSHOT
TABLE 56  ESCO TECHNOLOGIES  BUSINESS OVERVIEW
TABLE 57  COMPANY SNAPSHOT
TABLE 58  EMD SERONO INC BUSINESS OVERVIEW
TABLE 59  COMPANY SNAPSHOT
TABLE 60  MALAYSIA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 61  MALAYSIA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 62  INDONESIA IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 63  INDONESIA IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 64  PHILIPPINES IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 65  PHILIPPINES IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 66  THAILAND IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 67  THAILAND IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)
TABLE 68  VIETNAM IVF REVENUE BY END USERS, 2012 – 2020 ($MILLION)
TABLE 69  VIETNAM IVF CYCLES BY END USERS, 2012 – 2020 (THOUSAND)

 


LIST OF FIGURES

FIG. 1   ASIA PACIFIC IVF MARKET BY COUNTRY, 2013 & 2020 ($MILLION)
FIG. 2   ASIA PACIFIC IVF MARKET BY END USERS, 2012 – 2020 ($MILLION)
FIG. 3  PERCENTAGE OF PEOPLE WHO PERCEIVED VARIOUS INFERTILITY REASONS (SINGAPORE, THAILAND, INDONESIA AND CHINA)
FIG. 4   CHINA FERTILITY RATE (CHILDREN BORN/WOMEN)
FIG. 5   TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 6   TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) - SOUTH KOREA
FIG. 7   TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 8   TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 9   TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
FIG. 10  SINGAPORE FERTILITY RATE CHILD BORN/WOMEN
FIG. 11  MALAYSIA FERTILITY RATE CHILD BORN/WOMEN
FIG. 12  INDONESIA FERTILITY RATE CHILD BORN/WOMEN
FIG. 13  PHILIPPINES FERTILITY RATE CHILD BORN/WOMEN
FIG. 14  THAILAND FERTILITY RATE CHILD BORN/WOMEN
FIG. 15  VIETNAM FERTILITY RATE CHILD BORN/WOMEN

  

Countries in Asia Pacific with such lower levels of fertility have initiated innovative assistance programs to promote parenthood and provide subsidies on fertility treatments such as IVF. In addition, lower treatment cost as compared to western countries has also proved to be encouraging for the artificial reproductive treatment (ART) industry in the region.
SIMILAR MARKET STUDIES

Published Reports

In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market.
3 Jun 2014 | Price: $4515(SU) | View Details >>

The male infertility market is expected to grow to $301.5 million by 2020 with a CAGR of 4.9% during 2013-2020. Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. 20% of the total infertility is due to male factors. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing to the rise in male infertility levels. The major limitation experienced in the male infertility market is due to repeated treatment failures leading to an emotional impact on the patient.
29 Apr 2014 | Price: $4515(SU) | View Details >>

In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.
29 Jan 2014 | Price: $4515(SU) | View Details >>

Traditional wound care & closure and advanced wound care & closure products are used to treat acute and chronic wounds. Chronic wounds are hard to heal wounds, which take substantial time to heal and are expensive to treat. Advanced wound care & closure products are emerging as a standard solution for treating chronic wounds.
22 Jul 2014 | Price: $4515(SU) | View Details >>

Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices that has increased adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps which are bridged by the innovative CGM. With continuous glucose monitoring, significant improvement has been observed in stabilizing elevated A1C levels which in turn reduces risk of developing long term diabetic complications. Other driving factors for CGM market are technological innovation in the form of artificial pancreas, increasing awareness among developed, developing and under developed economies, and rise in incidences of diabetic cases.
17 Dec 2013 | Price: $4515(SU) | View Details >>

Upcoming Reports

Intravenous Access Devices are a prominent sector of the Healthcare industry. These devices are used by physicians for treating patients as well as testing blood after withdrawing it via intravenous route. Intravenous access devices are used for administering all the classes of drugs like antibiotics, antipyretics and analgesics. Rising incidences of different diseases such as tuberculosis, cancer and others are the key drivers of this market. Moreover, urbanization and growing geriatric population all over the world boost the growth of the Intravenous (IV) Access Devices market.
Price: $4515 | Pre Book Price: $5315 | View Details >>

An Arthroscopy is a procedure for diagnosing and treating joints related problems. It is used commonly to deal with the knees, wrist, ankles, elbows and shoulders. The rising awareness of different sports, many youngsters are involved in outdoor activities, which has increased injuries related to sports. Moreover, rise in obesity, growing aging population, and also increasing prevalence of musculoskeletal disorders such as rheumatoid arthritis, bone tumor, osteoarthritis and others are the drivers for the growth of this market. The report is considering advance and conventional medical equipments. The report provides a key trend that affects market growth, technology offerings and competitive landscape.
Price: $4515 | Pre Book Price: $5315 | View Details >>

Radiofrequency ablation is medical process, in which high frequency electromagnetic waves are used to generate heat for the treatment of medical conditions. It has applications in various fields of medicine such as pain management, cosmetology, cardiac rhythm management, oncology, renal denervation for hypertension.
Price: $4515 | Pre Book Price: $5315 | View Details >>

ECG Monitoring Systems are medical devices, which identify and give information about abnormal functioning of the heart. Rest ECG recorders, ECG stress testing systems, event recorders and Holter monitors are the part of ECG Monitoring systems. Cardiovascular diseases such as coronary heart diseases and strokes are estimated to be the leading cause of deaths worldwide. In order to prevent cardiovascular diseases, ECG Monitoring systems are used to detect abnormal heart functioning in patients.
Price: $4515 | Pre Book Price: $5315 | View Details >>

Skin is the outer covering of the human or animal’s body. It is the largest organ of the body and performs various functions such as protecting us from many harmful elements including microbes, enabling the sensations of heat, cold and touch and regulating our body temperatures. The goal of this report is to provide an overview of the global skincare devices markets with the current trends. Skincare devices are becoming popular due to the rising incidences of skin-related disorders. Additionally, they are widely used in aesthetics, which is a branch of philosophy dealing with beauty.
Price: $4515 | Pre Book Price: $5315 | View Details >>
NEED MORE INFORMATION?
Call
+1 617 674 413
PURCHASE OPTIONS

Single User
By obtaining a Single User License, you and your organization concur that only an individual uses this report either electronically or online. The right to use or stockpiling of the report should be confined only to one authorized computer. User will have authorization to print one duplicate of the report for individual use, yet may not be replicated for circulation. Additional copies for this report may also be order at discounted price for use by addition readers/users.
$5315

Multi User 
Multi-User license permits you to access the report from eight authorized computers. It does not permit you to display it on your company website and permits you to only print 5 copies of the report that shall not be reproduced for circulation.
$8315

Corporate  
With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report in is prohibited without the prior permission of Allied Market Research. The publisher will, in turn, regard the privacy of the purchaser and will keep it confidential. Upon buying single or multi-user license, buyer must provide the names and email ids of the authorized users of this report.
$11315


WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader






Top